Pharmacogenomics studies how genes affect your response to medications by combining the fields of pharmacology (the science of drugs) and genomics (the study of genes and what they do). For us, the goal of pharmacogenomics is to take the research that has been proven over the past 30 years and make it usable and actionable for physicians.
You should know which medications are right for you and their potential interactions—long before you even start taking them. According to an NPR-Truven Health Analytics Health Poll, 29 percent of people decided to stop taking a prescription because of negative side effects, and 15 percent of people said they stopped taking a drug because they didn’t think it was working.
With PGx testing, you get the data behind why and how your body metabolizes certain medications. Get tested to enable your providers proactively on medication management—not reactively.
As more people grow increasingly invested in their own health, technology is playing a vital role in connecting patients to their DNA. Translational Software’s pharmacogenomics testing can help your doctor or pharmacist see the efficacy and toxicity of certain drugs and provide the best care possible. PGx testing is for you if you:
"Translational Software understands pharmacogenomic testing better than anyone else in the field, and they were able to create a platform that seamlessly delivered on our vision."
Chief Medical Officer at 2bPrecise LLC
"Translational Software has taken the pioneering step of implementing the first pharmacogenomics solution that employs FHIR genomics for optimizing the prescription of patient medications, and has been a real leader in this arena."
Gil Alterovitz, Ph.D., a Harvard Medical School professor and co-chair of HL7’s Clinical Genomics Work Group
"Integrating Translational Software’s PGx knowledge base within our e-prescribing platform allows us to deliver an in-workflow, evidence-based approach to medication prescribing that can be used as part of routine care."
President of DrFirst
